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A BRIEF INTRODUCTION
Adult stem cells represent quiescent cells
that once prompted, they proliferate with
the potential to differentiate into a range of
progeny providing regenerative medicine
with novel tools for cure and rehabilita-
tion. However, the risk that these prolif-
erating stem cells could easily become a
tumor cell sets barriers for their use. But,
how are stem cells involved in tumor for-
mation? The answer is that they possess
a common mechanism: their ability for
proliferation, differentiation, and of self-
renewing beyond the body’s capabilities.
This exact trait is that makes stem cells
so promisable and terrifying at the same
moment, leading to Erebus. Tumors are
interpreted in two distinct ways. Either as
a disease, where the cause is interpreted
as a cellular/genomic malfunction or as a
reaction where the cause is interpreted as
a natural consequence of evolutionary ori-
gin. As a result, treatment modalities could
depend on this initial interpretation.
Generally though, tumorigenesis is
described as a normal cell initially being
transformed to a tumor cell that starts to
proliferate. This cell could be a differen-
tiated somatic cell or an adult stem cell
that could develop into a cancer stem cell
(CSC). It is crucial that a diagnosis of the
tumor to take place before any therapeutic
intervention. Most of the times therapies
involve surgical or chemical elimination of
the tumor. Thus at that point, the tissue
need for reconstruction would most prob-
ably implicate new stem cells that possess
the ability to recognize the site of defect,
locate it and initiate the reconstruction,
which involves regeneration.
THE STEM CELL THEORIES OF
CARCINOGENESIS
The link between stem cells and tumori-
genesis remains quite elusive. Tumors
could stem from CSCs (Oishi and Wang,
2011), as evidence suggests for different
tumors types, such as glioblastoma (Singh
et al., 2003, 2004) breast cancer (Jain
and Alahari, 2011), ovarian cancer (Curley
et al., 2011) and gastrointestinal cancer
(Davies et al., 2011; Skoudy et al., 2011;
Zheng et al., 2011). Furthermore, there is
a strong debate on the existence or not of
a rare CSC population in childhood acute
lymphoblastic leukemia (ALL). An inter-
esting report by Greaves (2010) highlights
that there are three main attributions to
cancer propagation: (a) a fixed and hier-
archically positioned subset of stem cells
resembling normal hematopoietic stem
cells, (b) a non-deterministic or stochastic
process with plasticity of “stemness” and
(c) the activity of a genetically dominant
sub-clone (Greaves, 2010). Above recent
findings suggest also a definite role of stem
cells in carcinogenesis.
CANCER: THE WOUND THAT NEVER
HEALS
Tumors have been considered as wounds
that never heal, while the connections
between cancer, inflammation and local
tissue repair have been reported exten-
sively. These are very interesting topics,
which brings up the notion that dif-
ferent phenotypes of cellular pathology
could emerge from similar gene regu-
latory mechanisms. An interesting con-
cept is presented by Riss et al. (2006)
who proposes that tissue regeneration and
tumorigenesis are probably two relatives
that differ in some minor details. Both
phenomena are very complex, they do
however share some common characteris-
tics. The application of the term “wound”
was given to cancer by Dvorak (1986),
highlighting the fact that both wound
healing and tumor development require a
microenvironment and a support of stro-
mal cells in order to occur.
THE MICROENVIRONMENT
Last but not least, an interesting question
arises. What does the microenvironment,
or in other words “the niche”, have to
contribute for cell reconstruction? An
interplay between CSCs and microen-
vironment has been observed in colon
cancer, where the pluripotency of CSCs is
maintained at the base of colon crypts
influenced by fibroblast, endothelium
and inflammatory cells, cytokines and
growth factors secreted by these cells (in
particular HGF) and by that means ulti-
mately the balance between self-renewal
and differentiation of the staminal pop-
ulation is regulated (Adegboyega et al.,
2002; De Sousa et al., 2011; Catalano et al.,
2013). Epithelial-Mesenchymal Transition
(EMT)-inducing factors released by the
surrounding tumor microenvironment
can affect the invasive phenotype in the
initiation of epithelial malignancies (Le
et al., 2008). Key regulators of this pro-
cess are TGFA, through the activation
of Twist, SLUG, ZEB2, and PI3K/Akt,
which increase the mTOR kinase expres-
sion, Shh and Wnt (Gulhati et al., 2011).
As feeding becomes an urgent require-
ment to support the rapid growth of the
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tumor, microenvironmental stimuli facil-
itate CSCs vasculature crosstalk. Indeed,
tumor microenvironment orchestrates a
vascular niche formation, determining
the fate of CSCs (Calabrese et al., 2007).
Numerous reports have highlighted the
“rail tracks” metaphor and the crucial role
of the microenvironment in the develop-
ment and maintenance of tumors as well
as healthy tissues. For example, such a
study mentioned the existence of variant
subpopulations within the same ovarian
tumor emerging under the influence of
different microenvironments (Abelson
et al., 2013). An interesting debate is
focused on the role of mesenchymal stem
cells, as they can manifest a dual mech-
anism of action, that is tumor-inducing
as well as tumor suppressing, linking the
role of the microenvironment to tumor
progression (Yagi and Kitagawa, 2013).
Stem cells, as neural stem cells, employ
intrinsic factors together with extrin-
sic determinants to acquire flexibility
in their response to their niche signals
during self-renewal and/or differenti-
ation (Charalampopoulos et al., 2008;
Remboutsika et al., 2011). Conclusively,
on one hand, the concept of a “rail track”
that determines the fate of cells is sim-
ple and self-explanatory. The problem is
that there is not only one cross-road, but
probably a network of rail-roads, where
decisions are taken on the spot. Those
are the fate-determining steps and their
plethora, challenges our comprehension
capabilities.
PROLIFERATION vs. REGENERATION
Thus, the key to developing novel and
effective therapies lies with the under-
standing of cell growth mechanics and
proliferation (Oviedo and Beane, 2009;
Lambrou et al., 2013). On one hand, pro-
liferation can be regarded as the leading
effect of cancer, but whether this is the
“aetion” (cause) (Gr. Aıτιoν) or the “aetia-
ton” (causative) (Gr. Aıτıατóν) remains to
be elucidated. From the beginning of the
century a connection has been established
between tumor growth and embryologi-
cal cell growth. It was first reported by
Waddington who mentioned and linked
oncogenic mechanisms as possible regen-
eration mechanisms (Waddington, 1935).
In particular, he stated “. . . the individua-
tion field, then, is the agent which controls
the growth of the different parts in a har-
monious way so that a normal individual
is formed. In later life, the individuation
field splits up into smaller separate fields,
such as leg fields, head fields, etc. These are
the agents from whom cancerous growth has
escaped. . . ”. His work has been generally
neglected in the literature, as it states that
uncontrolled growth could be linked to
controlled developmental growth (Slack,
2002). Furthermore, from the beginning
of the century it has been evident that
proliferation and regeneration are two dif-
ferent things. The process of regeneration,
as it was observed in the embryogene-
sis of lower species, was derived from
experimental results of transplantation in
frog embryos (Needham, 1936). Another
aspect of regeneration, which involves pre-
existing tissue remodeling, has also been
observed from the beginning of the twen-
tieth century by Morgan, and was termed
morphalaxis (Morgan, 1901). In general, a
regenerative event always seeks to main-
tain or to re-establish the form and the
function of tissue cells, a process called
morphostasis. However, regeneration could
emerge from tumor cells and as a result,
tissue recovery becomes linked to cancer-
related cellular anomalies (Beachy et al.,
2004; Gurtner et al., 2008; Schafer and
Werner, 2008; Pellettieri et al., 2010).
Namely, regeneration could involve the
emergence of abnormal growth, and there-
fore tumor growth. Based on this aspect
a hypothesis is formulated. This is that
the regeneration process itself, may bring
under control the autonomous growth of
tumor cells. The problem is that tumor
emergence differs from tumor to tumor.
For example, epithelial tumors and sar-
comas have different mechanisms of pro-
gression and ontogenesis than other tumor
types (Gibbs et al., 2005; Di Fiore et al.,
2009; Lambrou et al., 2013).
As mentioned, cancer cells are able to
proliferate as stem cells do. Stem cells pro-
liferate in an orderly manner, giving rise
to a part of tissue or organ. Tumor cells
though are thought to undergo uncon-
trollable proliferation rounds. Yet, even
tumor cells grow with a “concept in mind”.
They form a pattern of growth and the
“organ” developed is per se a viable organ-
ism in itself. From this concept, several
motivating notions arise. Which function
appears first, the ability to proliferate or
the ability to regenerate? Obviously, pro-
liferation does not always mean regener-
ation as in the case of cancer, yet for the
tumor itself it is regeneration. If a tumor
grows in an orderly manner, then for its
own standards this growth is regeneration.
Even the ability to grow to a sizeable struc-
ture after intense treatment is a way of
regeneration, regardless of the fact that this
type of growth is fatal for the implicated
organism.
If we consider that stem cells exhibit
two main traits, meaning the capacity to
proliferate and the potential to differenti-
ate, exactly the same traits are present in
tumor cells. So what is the discriminating
trait between the two cell types? The most
obvious answer would be that the former
grow to the benefit of the organism, while
the latter to its harm. More precisely, it is
suggested that tumor cells are stem cells,
which are generated at the wrong place
and/or time. Stem cells could be poten-
tially the cause for tumorigenesis, when
they are allocated to a tumor-instructive
microenvironment. Yet, could cancer cells
be in reality stem cells that start to prolif-
erate in an uncontrollable manner creat-
ing the tumor? Is proliferation somehow
always linked to regeneration? An imme-
diate answer to this question would be no,
since tumor cells do proliferate but they do
not regenerate, while stem cells do regen-
erate when they proliferate. However, this
depends on the definition of regeneration,
as mentioned in the previous paragraph.
Seen from the tumor “point of view”, a tis-
sue with defined characteristics, which is
damaged by chemotherapy, radiation or
surgery, and can recover with great effi-
ciency, can be defined as regeneration.
Therefore, it is not easy to discriminate
between proliferation and regeneration. It
seems so that a stem cell could give rise
to two different types of daughter cells.
The first could lead to a healthy tissue
cell, while the latter to a tumor cell. This
cell fate decision between the two “rail
tracks” lies most possibly in the microen-
vironment in which each cell is placed.
Tumor cells were probably not ab initio
tumor cells; they were normal cells, includ-
ing both somatic differentiated cells, and
stem cells, and developed into cancerous
cells due to unknown etiologies.
If were to “baptize” each cell type with
a name by citing the famous movie by
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Sergio Leone, it would be easy to attribute
the term “Good” to a stem cell able to
regenerate and produce healthy tissue in
replacement of a damaged tissue; “Bad”
to a stem cell that becomes tumorigenic
and converts the proliferation process to
a disease expression; and the term “Ugly”
to the venerable stem/tumor cell, which
still hasn’t committed its cell fate. In other
words, cells that are on a railroad track
and their path is determined by numerous
circumstances.
It is profound that stem cell treatment
appears as a promising tool for both can-
cer and organ regeneration treatments.
Undoubtedly, this is a fascinating area
of intense research and much is yet to
be learned about the biology of tumor
and stem cells and their interconnect-
ing pathways. Then, the comprehension
of the delicate boundaries between pro-
liferation and regeneration will reveal the
“mysteries” of healing.
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